Unveiling the nephrotoxic profile of BCR‐ABL tyrosine kinase inhibitors: A real‐world experience in Africa

Abstract Introduction The efficacy of BCR‐ABL tyrosine kinase inhibitors (TKIs) in treating chronic myelogenous leukemia and other malignancies is well‐documented. However, concerns about potential nephrotoxicity have raised questions. This study, conducted at Tikur Anbesa Specialized Hospital (TASH...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Zekarias Seifu Ayalew, Gebeyehu Tessema Azibte, Fisihatsion Tadesse, Biruk Abate Legesse, Zerubabel Getahun Kiflu, Mahlet Tsige Weldeamanuel, Kibrekidusan Aynekulu Tsige, Bereket Abraha Molla, Addisu Melkie Ejigu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2024-08-01
Edice:	eJHaem
Témata:	BCR‐ABL CML renal toxicities tyrosine kinase inhibitors
On-line přístup:	https://doi.org/10.1002/jha2.988
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!